Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment. - Wikidata - wikimedia - TriplyDB

Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment.

Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment.

http://www.wikidata.org/entity/Q37833152

about

Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer.Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin CUA guidelines on the management of non-muscle invasive bladder cancer.Current intravesical therapy for non-muscle invasive bladder cancer.Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?[Urine cytology - update 2013. A systematic review of recent literature].

P2860

Q35578796-962CF169-996F-4741-A358-DD1B54BB69DF Q35681850-7BDE9375-149A-422F-A95C-EF73EBF47801 Q35898208-9BAB2E72-878D-43E1-AA22-5DC7C9B97BF3 Q36326208-71E168C1-7630-4C6F-A4DE-38B599593AC9 Q38129947-77A1C9A3-7C4D-40A6-AEAD-FC43331449FE Q38316336-EB73C667-58D2-4055-A562-AE06BE1B3EAD Q45139625-52826859-6D74-428E-9CE3-9ADFF767DDFA

P2860

Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment.

http://www.wikidata.org/entity/Q37833152

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term follow-up of T1 high ...... lle Calmette-Guérin treatment.

@en

Long-term follow-up of T1 high ...... lle Calmette-Guérin treatment.

@nl

type

label

Long-term follow-up of T1 high ...... lle Calmette-Guérin treatment.

@en

Long-term follow-up of T1 high ...... lle Calmette-Guérin treatment.

@nl

prefLabel

Long-term follow-up of T1 high ...... lle Calmette-Guérin treatment.

@en

Long-term follow-up of T1 high ...... lle Calmette-Guérin treatment.

@nl

P1433

Q37833152-685E0962-FC9F-4B70-AD7E-6E351F884801

P1476

Q37833152-E18EE0E9-CC81-4DF9-905A-B906B26FC84C

P2093

Q37833152-02E29066-6E33-4290-BC7B-5ADADDDD01CC

Q37833152-133FDC1C-2070-41D3-ADB5-C75D79969943

Q37833152-13A6D5D7-7A22-4CA5-835C-F7FFA6351762

Q37833152-265693AE-5846-4007-A73F-CEA1B1743B68

Q37833152-33353F31-4D32-4D78-AD7E-5C606067B1A0

Q37833152-39220D59-C149-433E-ACA8-CD6EE964D7EE

Q37833152-44C57F63-EFA6-42E3-B995-2879BF926D06

Q37833152-475F2DC1-BF2C-4519-8B62-F6C43F58985C

Q37833152-5A71343A-818B-4353-88F2-B063A239F673

Q37833152-68616D34-DC1B-4BC1-BF6A-D60B16882AD6

P2860

Q37833152-01FCE778-3EC0-478B-9682-152BC9A44B23

Q37833152-1187EAB8-07E9-4E68-8D7E-975873B5EA74

Q37833152-235A0E4D-D820-4A62-837D-4D8B67FFBCC7

Q37833152-27822827-DF76-4D7C-A453-5F5F42C2E053

Q37833152-49EA6651-0632-476B-A8AD-72597333F940

Q37833152-4D16EF3B-6672-48C9-974D-6339810470C6

Q37833152-543AA13B-E89A-4598-8B5B-A12F2993549F

Q37833152-6F30FE99-856A-4306-98EC-0B13D7A29894

Q37833152-7827BB73-E41D-4D5E-8245-285785F1D25E

Q37833152-871F64B7-298C-4B26-A818-7FD82887DF6F

P304

Q37833152-9A8C8C75-B828-488B-A76E-24E6657AC01D

P31

Q37833152-2F94F135-2168-4EB5-98E5-BE81320348C5

P356

Q37833152-8633F09E-552E-4102-81DE-995F2C08796A

P433

Q37833152-30ECF1BC-E772-4F2A-9C27-B8F7644B6B40

P478

Q37833152-343D8431-EBF6-4B36-A041-E68F419DAF61

P50

Q37833152-0D65C98D-864D-42DD-BFBD-2ABA483FE383

P577

Q37833152-6C591CA7-90E8-4093-83B3-D6F38E7F74DB

P698

Q37833152-17BF285B-0E38-44EA-802B-E16759F8A99B

P356

J.1464-410X.2010.09572.X

P1433

BJU International

P1476

Long-term follow-up of T1 high ...... lle Calmette-Guérin treatment.

@en

P2093

Alex Kostynsky

http://www.w3.org/2001/XMLSchema#string

Alexandre R Zlotta

http://www.w3.org/2001/XMLSchema#string

Antonio Finelli

http://www.w3.org/2001/XMLSchema#string

Bas W G van Rhijn

http://www.w3.org/2001/XMLSchema#string

Chris H Bangma

http://www.w3.org/2001/XMLSchema#string

Cynthia Kuk

http://www.w3.org/2001/XMLSchema#string

David M Kakiashvili

http://www.w3.org/2001/XMLSchema#string

Greg Trottier

http://www.w3.org/2001/XMLSchema#string

Julian Azuero

http://www.w3.org/2001/XMLSchema#string

Michael A S Jewett

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.

A second-look TUR in T1 transitional cell carcinoma: why?

Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.

Management of stage T1 tumors of the bladder: International Consensus Panel.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

The optimal management of T1G3 bladder cancer.

Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.

The treated natural history of high risk superficial bladder cancer: 15-year outcome.

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

P304

540-546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2010.09572.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Theodorus H Van der Kwast

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21276177

http://www.w3.org/2001/XMLSchema#string